We are Genmab

Engineering a transformative tomorrow 

As a leading international biotechnology company, we believe in the transformative power of science and technology. 

Learn more

Research & Innovation

Antibody Architects

How we use insights into new formats of antibodies to turn them into medicines for patients.

Watch video


Annual General Meeting 2023

Genmab A/S’ Annual General Meeting 2023 took place on Wednesday, March 29.

Learn more and replay the webcast

Engineering a transformative tomorrow 

Antibody Architects

Annual General Meeting 2023

We are a fast-growing, international biotech company committed to our goal of improving the lives of patients through innovative and differentiated
antibody therapeutics.

Load more

On the lookout for a life-changing career?

Join our team of extra[not]ordinary people and become part of a company working to pioneer antibody medicines for cancer and other serious diseases. 

Explore your career opportunities

You are now leaving Genmab.com to go to our collaborator’s website. If you continue, we encourage you to read the website’s privacy and cookie policy.